Research Projects & Grants

For Profit Organization

• A phase 2/3, randomized, double-masked, sham-controlled trial of QPI-1007 delivered by single or multi-dose intravitreal injection(s) to subjects with acute nonarteritic anterior ischemic optic neuropathy (NAION), Role: Investigator, Quark Pharmaceuticals, (01/2019 - 01/2020) Status: Completed
• The efficacy and safety of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension, Role: Investigator, Allergan Inc., (01/2019 - 01/2020) Status: Completed